Copyright 2025 The Associated Press. All Rights Reserved. Dakota Access pipeline protesters defy law enforcement officers who are trying to force them from a camp on ...

Eikon Therapeutics has secured $350.7 million in Series D financing to advance its clinical stage programs and expand its pipeline. The latest funding round brings the company’s total private funding ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.

(AP Photo/Jim Mone, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Enbridge Energy’s plans to build a protective tunnel around an aging pipeline that runs beneath a channel ...

Biogen Inc. (NASDAQ: BIIB ... The company is also focused on advancing its rare disease and immunology pipeline in 2025, which includes Phase 3 trials for Felzartamab, a treatment for multiple ...

The approval of Spinraza in 2016 and Qalsody in 2023 provided a solid foundation for Ionis' neurology pipeline. Partner Biogen's reported Spinraza revenue of roughly $2 billion annually in 2019-21 ...

Analysts project peak sales of $1.7 billion, although the path to reaching this figure may be gradual. Biogen's pipeline has faced setbacks, including the discontinuation of SAGE-324 for essential ...